117 related articles for article (PubMed ID: 22238429)
1. Study on CCR5 analogs and affinity peptides.
Wu Y; Deng R; Wu W
Protein Eng Des Sel; 2012 Mar; 25(3):97-105. PubMed ID: 22238429
[TBL] [Abstract][Full Text] [Related]
2. Molecular anatomy of CCR5 engagement by physiologic and viral chemokines and HIV-1 envelope glycoproteins: differences in primary structural requirements for RANTES, MIP-1 alpha, and vMIP-II Binding.
Navenot JM; Wang ZX; Trent JO; Murray JL; Hu QX; DeLeeuw L; Moore PS; Chang Y; Peiper SC
J Mol Biol; 2001 Nov; 313(5):1181-93. PubMed ID: 11700073
[TBL] [Abstract][Full Text] [Related]
3. Identification of a linear peptide recognized by monoclonal antibody 2D7 capable of generating CCR5-specific antibodies with human immunodeficiency virus-neutralizing activity.
Khurana S; Kennedy M; King LR; Golding H
J Virol; 2005 Jun; 79(11):6791-800. PubMed ID: 15890918
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibody screening of a phage-displayed random peptide library reveals mimotopes of chemokine receptor CCR5: implications for the tertiary structure of the receptor and for an N-terminal binding site for HIV-1 gp120.
Königs C; Rowley MJ; Thompson P; Myers MA; Scealy M; Davies JM; Wu L; Dietrich U; Mackay CR; Mackay IR
Eur J Immunol; 2000 Apr; 30(4):1162-71. PubMed ID: 10760806
[TBL] [Abstract][Full Text] [Related]
5. Large-scale expression and purification of the major HIV-1 coreceptor CCR5 and characterization of its interaction with RANTES.
Nisius L; Rogowski M; Vangelista L; Grzesiek S
Protein Expr Purif; 2008 Oct; 61(2):155-62. PubMed ID: 18588983
[TBL] [Abstract][Full Text] [Related]
6. Recognition of RANTES by extracellular parts of the CCR5 receptor.
Duma L; Häussinger D; Rogowski M; Lusso P; Grzesiek S
J Mol Biol; 2007 Jan; 365(4):1063-75. PubMed ID: 17101151
[TBL] [Abstract][Full Text] [Related]
7. Theoretical studies on the interactions and interferences of HIV-1 glycoprotein gp120 and its coreceptor CCR5.
Da LT; Wu YD
J Chem Inf Model; 2011 Feb; 51(2):359-69. PubMed ID: 21284403
[TBL] [Abstract][Full Text] [Related]
8. Restricted variable residues in the C-terminal segment of HIV-1 V3 loop regulate the molecular anatomy of CCR5 utilization.
Hu Q; Napier KB; Trent JO; Wang Z; Taylor S; Griffin GE; Peiper SC; Shattock RJ
J Mol Biol; 2005 Jul; 350(4):699-712. PubMed ID: 15964018
[TBL] [Abstract][Full Text] [Related]
9. Evidence as a HIV-1 self-defense vaccine of cyclic chimeric dodecapeptide warped from undecapeptidyl arch of extracellular loop 2 in both CCR5 and CXCR4.
Misumi S; Takamune N; Ido Y; Hayashi S; Endo M; Mukai R; Tachibana K; Umeda M; Shoji S
Biochem Biophys Res Commun; 2001 Aug; 285(5):1309-16. PubMed ID: 11478800
[TBL] [Abstract][Full Text] [Related]
10. Nonproductive human immunodeficiency virus type 1 infection of human fetal astrocytes: independence from CD4 and major chemokine receptors.
Sabri F; Tresoldi E; Di Stefano M; Polo S; Monaco MC; Verani A; Fiore JR; Lusso P; Major E; Chiodi F; Scarlatti G
Virology; 1999 Nov; 264(2):370-84. PubMed ID: 10562499
[TBL] [Abstract][Full Text] [Related]
11. NMR evidence of charge-dependent interaction between various PND V3 and CCR5 N-terminal peptides.
Galanakis PA; Kandias NG; Rizos AK; Morikis D; Krambovitis E; Spyroulias GA
Biopolymers; 2009; 92(2):94-109. PubMed ID: 19117029
[TBL] [Abstract][Full Text] [Related]
12. Conformational changes of gp120 in epitopes near the CCR5 binding site are induced by CD4 and a CD4 miniprotein mimetic.
Zhang W; Canziani G; Plugariu C; Wyatt R; Sodroski J; Sweet R; Kwong P; Hendrickson W; Chaiken I
Biochemistry; 1999 Jul; 38(29):9405-16. PubMed ID: 10413516
[TBL] [Abstract][Full Text] [Related]
13. Construction, purification, and immunogenicity of recombinant cystein-cystein type chemokine receptor 5 vaccine.
Wu K; Xue X; Wang Z; Yan Z; Shi J; Han W; Zhang Y
Protein Expr Purif; 2006 Sep; 49(1):108-13. PubMed ID: 16600624
[TBL] [Abstract][Full Text] [Related]
14. Electrostatic modeling of peptides derived from the V3-loop of HIV-1 gp120: implications of the interaction with chemokine receptor CCR5.
Morikis D; Rizos AK; Spandidos DA; Krambovitis E
Int J Mol Med; 2007 Mar; 19(3):343-51. PubMed ID: 17273779
[TBL] [Abstract][Full Text] [Related]
15. Antiviral chemokines: intracellular life of recombinant C-C chemokine RANTES.
Owais M; Arya SK
J Hum Virol; 1999; 2(5):270-82. PubMed ID: 10551733
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of HIV-1 infection by synthetic peptides derived CCR5 fragments.
Imai M; Baranyi L; Okada N; Okada H
Biochem Biophys Res Commun; 2007 Feb; 353(4):851-6. PubMed ID: 17210123
[TBL] [Abstract][Full Text] [Related]
17. CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5.
Trkola A; Dragic T; Arthos J; Binley JM; Olson WC; Allaway GP; Cheng-Mayer C; Robinson J; Maddon PJ; Moore JP
Nature; 1996 Nov; 384(6605):184-7. PubMed ID: 8906796
[TBL] [Abstract][Full Text] [Related]
18. Identification of ENV determinants in V3 that influence the molecular anatomy of CCR5 utilization.
Hu Q; Trent JO; Tomaras GD; Wang Z; Murray JL; Conolly SM; Navenot JM; Barry AP; Greenberg ML; Peiper SC
J Mol Biol; 2000 Sep; 302(2):359-75. PubMed ID: 10970739
[TBL] [Abstract][Full Text] [Related]
19. Selection of CC chemokine receptor 5-binding peptide from a phage display peptide library.
Wang FY; Zhang TY; Luo JX; He GA; Gu QL; Xiao F
Biosci Biotechnol Biochem; 2006 Sep; 70(9):2035-41. PubMed ID: 16960395
[TBL] [Abstract][Full Text] [Related]
20. Design of immunogens that present the crown of the HIV-1 V3 loop in a conformation competent to generate 447-52D-like antibodies.
Chakraborty K; Durani V; Miranda ER; Citron M; Liang X; Schleif W; Joyce JG; Varadarajan R
Biochem J; 2006 Nov; 399(3):483-91. PubMed ID: 16827663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
